The newly discovered conjunctive use of GLP-1RA can improve clinical outcomes in patients with multiple chronic illnesses that have overlapping pathophysiology and help improve quality of life with early introduction
Some practitioners recommend maintaining the pinch, but releasing it allows the tissue to settle naturally around the needle, which can actually improve medication dispersion
ClinicalTrials.gov: NCT04881760 (Phase 2, Obesity), NCT04867785 (Phase 2, T2D) Questions to ask your doctor Given my health history, is a GLP-1 medication appropriate for me at all
They are either unable to reach their target goal while taking them, or they find that their weight creeps up after they try to stop using them
The incretin hormone glucagon-like peptide-1 (GLP-1) is secreted from the intestinal L cells in response to the nutrient ingestion and potentiates glucose-dependent insulin secretion in healthy individuals 1,2
Both are excellent options under physician supervision